1105 GMT - Dassault Systemes's cut to its full-year guidance is deeper than expected and comes alongside fresh signs of weakness at its Medidata business, UBS analysts say in a research note. The French software company lowered its guidance for full-year revenue growth excluding currency movements to 4% to 6%, down from a 6% to 8% range previously, though it reiterated its outlook for earnings-per-share growth at constant foreign-exchange rates. Software revenue is now expected to grow less than previously anticipated, with licenses forecast to drop by as much as 8% or be flat at best, with a very wide range of outcomes for the fourth quarter, UBS says. Moreover, Dassault's Medidata business was hit by a decline in starts of life-science studies, which won't be well received by investors, the analysts say. Shares fall 15%.(adria.calatayud@wsj.com)

(END) Dow Jones Newswires

October 23, 2025 07:05 ET (11:05 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.